GLSI Insider Trading

Insider Ownership Percentage: 51.67%
Insider Buying (Last 12 Months): $3,060,653.50
Insider Selling (Last 12 Months): $0.00

Greenwich LifeSciences Insider Trading History Chart

This chart shows the insider buying and selling history at Greenwich LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$24kbought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

Greenwich LifeSciences Share Price & Price History

Current Price: $13.11
Price Change: Price Increase of +0.23 (1.79%)
As of 01/6/2025 05:00 PM ET

This chart shows the closing price history over time for GLSI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
FebMarAprMayJunJulAugSepOctNovDecJan$13.11Closing price on 01/06/25:

SEC Filings (Institutional Ownership Changes) for Greenwich LifeSciences (NASDAQ:GLSI)

4.16% of Greenwich LifeSciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GLSI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
202220232024$749kbought$26ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$500k$0$500kTotal InflowsTotal Outflows
Greenwich LifeSciences logo
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Read More on Greenwich LifeSciences

Today's Range

Now: $13.11
Low: $12.95
High: $13.50

50 Day Range

MA: $13.18
Low: $10.91
High: $14.95

52 Week Range

Now: $13.11
Low: $8.00
High: $21.44

Volume

44,060 shs

Average Volume

43,153 shs

Market Capitalization

$172.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

Who are the company insiders with the largest holdings of Greenwich LifeSciences?

Greenwich LifeSciences' top insider shareholders include:
  1. Snehal Patel (CEO)
  2. Jaye Thompson (VP)
Learn More about top insider investors at Greenwich LifeSciences.